NCT03220022 2026-04-13Ibrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With HIV-Positive Stage II-IV Diffuse Large B-Cell LymphomasNational Cancer Institute (NCI)Phase 1 Active not recruiting46 enrolled 19 charts